RPR-107393

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameRPR-107393
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene synthase inhibitors
TargetsSqualene synthase
Therapy Area/IndicationsHyperlipidemiasAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Aventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Aventis
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A